| Preferred Name |
Nivocasan |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C98213 |
| CAS_Registry |
908253-63-4 |
| Chemical_Formula |
C21H22FN3O5 |
| code |
C98213 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| FDA_UNII_Code |
9554OW6MVU |
| FULL_SYN |
LB84451 LB-84451 5-isoxazolecarboxamide, N-((2S,3S)-2-(fluoromethyl)tetrahydro-2-hydroxy-5-oxo-3-furanyl)-4,5-dihydro-3-(1-isoquinolinyl)-5-(1-methylethyl)-, (5R)- (5R)-N-((2S,3S)-2-(Fluoromethyl)-2-hydroxy-5-oxo-tetrahydrofuran-3-yl)-3-(isoquinolin- 1-yl)-5-(1-methylethyl)-4,5-dihydroisoxazole-5-carboxamide NIVOCASAN GS-9450 Nivocasan |
| label |
Nivocasan |
| Preferred_Name |
Nivocasan |
| prefixIRI |
Thesaurus:C98213 |
| prefLabel |
Nivocasan |
| Semantic_Type |
Pharmacologic Substance |
| UMLS_CUI |
C3273880 |
| subClassOf |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| There are currently no mappings for this class. | |||